News

Now add in the odds of you being born you — not your brother, not your sister, not your cousin. You. Binazir says, “When you ...
Earth has experienced both hot and cold periods over time, though warm times have been more common. That’s true of the last 485 million years, as seen in this timeline reported in 2024. Our genus, ...
Researchers used zircons and AI to reconstruct Earth's ancient crust, revealing possible tectonic processes from the planet's ...
The Nato Modelling and Simulation Centre of Excellence revealed progress on existing projects and future plans involving AI.
Along the eastern shore of Hudson Bay in Canada’s northeastern province of Quebec, near the Inuit municipality of Inukjuak, resides a belt of volcanic rock that displays a blend of dark and light ...
The firm will use the money to advance its lead FAP-targeting radioligand candidate into clinical development.
Actithera, a radiopharmaceutical biotech pioneering precision radioligand therapies, has closed an oversubscribed Series A round of $75.5 million. The financing was co-led by founding investor M ...
Series A co-led by founding investor M Ventures and new lead investors Hadean Ventures, Sofinnova Partners, and 4BIO Capital with syndicate including Bioqube Ventures, Surveyor Capital and others ...
BIO investing in unique radiopharmaceutical platform company, developing radioligands with prolonged tumour retention Series A was co-led by 4BIO Capital, founding investor M Ventures, Hadean Ventures ...
BIO investing in unique radiopharmaceutical platform company, developing radioligands with prolonged tumour retention Series A was co-led by 4BIO Capital, founding investor M Ventures, Hadean Ventures ...
Actithera, a radiopharmaceutical biotech company translating medicinal chemistry insights into next-generation radioligand therapies (RLTs), today announced the close of an oversubscribed $75.5 ...